- Home
- CRTO vs IMCR Comparison
CRTO vs IMCR Comparison
Compare CRTO & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRTO
- IMCR
- Stock Information
- Founded
- CRTO 2005
- IMCR 2008
- Country
- CRTO France
- IMCR United Kingdom
- Employees
- CRTO N/A
- IMCR N/A
- Industry
- CRTO Advertising
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CRTO Consumer Discretionary
- IMCR Health Care
- Exchange
- CRTO Nasdaq
- IMCR Nasdaq
- Market Cap
- CRTO 2.3B
- IMCR 1.7B
- IPO Year
- CRTO 2013
- IMCR 2021
- Fundamental
- Price
- CRTO $34.21
- IMCR $32.93
- Analyst Decision
- CRTO Buy
- IMCR Buy
- Analyst Count
- CRTO 10
- IMCR 14
- Target Price
- CRTO $53.78
- IMCR $74.75
- AVG Volume (30 Days)
- CRTO 251.2K
- IMCR 267.8K
- Earning Date
- CRTO 10-30-2024
- IMCR 11-05-2024
- Dividend Yield
- CRTO N/A
- IMCR N/A
- EPS Growth
- CRTO 1230.66
- IMCR N/A
- EPS
- CRTO 1.65
- IMCR N/A
- Revenue
- CRTO $1,956,857,000.00
- IMCR $280,914,000.00
- Revenue This Year
- CRTO N/A
- IMCR $25.60
- Revenue Next Year
- CRTO $6.88
- IMCR $10.63
- P/E Ratio
- CRTO $24.81
- IMCR N/A
- Revenue Growth
- CRTO 1.64
- IMCR 27.95
- 52 Week Low
- CRTO $22.10
- IMCR $29.72
- 52 Week High
- CRTO $49.93
- IMCR $76.98
- Technical
- Relative Strength Index (RSI)
- CRTO 56.27
- IMCR 52.76
- Support Level
- CRTO $40.63
- IMCR $31.10
- Resistance Level
- CRTO $43.76
- IMCR $35.47
- Average True Range (ATR)
- CRTO 1.12
- IMCR 1.49
- MACD
- CRTO 0.23
- IMCR 0.17
- Stochastic Oscillator
- CRTO 74.54
- IMCR 51.98
About CRTO Criteo S.A.
Headquartered in Paris, Criteo is one of the leading ad-tech companies in the digital advertising market. Its technology, allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. The firm also provides technology allowing retailers to effectively manage their ad inventories and improve yield optimization.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.